HEMESIGHT
LIVE

Serial Number

79305516

Owner

Otsuka Pharmaceutical Co., Ltd.

Attorney

Kazuyo Morita

Filing Date

Dec 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HEMESIGHT Trademark

Serial Number: 79305516 • Registration: 6733728

HEMESIGHT is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on December 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (566 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

December 15, 2020

Registration Date

May 24, 2022

Published for Opposition

March 8, 2022

Goods & Services

Diagnostic preparations for medical purposes for diagnosing and treating cancer through genetic testing; diagnostic reagents for medical use in diagnosing cancer

Providing medical information in the field of genetic and sequencing testing for the diagnosis and treatment of cancer; medical diagnostic services in the nature of performing diagnosis of disease in the field of cancer diagnostics; medical testing for diagnostic or treatment purposes, namely, genetic testing and sequencing tests for diagnosis and treatment of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 13, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 2, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 8, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 8, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Mar 7, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 16, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 16, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 28, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 28, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 28, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 28, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 16, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 16, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 16, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 11, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 4, 2021 REPR